People · Operator
Named in public records as an officer, director or promoter · active 2013–2020 · Healthtech, Other Health Care, Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cala Health, Inc. | — | Healthtech | Series C | $166.1M | $369.8M | 2018 |
| NeuMoDx Molecular, Inc. | — | Other Health Care | Series B | $54.8M | $444.0M | 2014 |
| Strata Oncology, Inc. | — | Pharma | Series A | $29.2M | $27.0M | 2018 |
| Molecular Imaging, Inc. | — | Biotechnology | Series A | $12.0M | $55.5M | 2013 |
Nicole Walker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nicole Walker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey Williams | 2 | 10 |
| Jan Garfinkle | 2 | 7 |
| William Burkoth | 2 | 5 |
| David Rubin | 1 | 11 |
| James Pavlik | 1 | 9 |
| Michael Gross | 1 | 9 |
| Christopher O'Donnell | 1 | 8 |
| Michael Carusi | 1 | 7 |
| Stephen Sullivan | 1 | 6 |
| Michael A. Carusi | 1 | 6 |
| John Kuelper | 1 | 6 |
| Renee Ryan | 1 | 6 |
| Edward Michael | 1 | 6 |
| James Lee | 1 | 5 |
| Keith Flaherty | 1 | 5 |
| Juan-Pablo Mas | 1 | 5 |
| Peter Shagory | 1 | 5 |
| STACY ENXING SENG | 1 | 5 |
| ROBERT PAULL | 1 | 4 |
| NEIL TIWARI | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.